Back to search

Modulation of an Acquired Coagulation Factor V Inhibitor with Intravenous Immune Globulin

Data up to Jan 2025

Published1997
Citations40
References32

Total Citations Per Year

Abstract

References (32)

HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD

1981 • 1,659 citations

ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN

1984 • 485 citations

Isolation of functional human coagulation factor V by using a hybridoma antibody.

1981 • 208 citations

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin

1990 • 186 citations

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin

1990 • 182 citations

Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

1993 • 180 citations

Isolation and study of an acquired inhibitor of human coagulation factor V.

1986 • 172 citations

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

1995 • 171 citations

Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients

1993 • 161 citations

Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin

1992 • 132 citations

Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy

1983 • 128 citations

Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis

1994 • 123 citations

Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions

1980 • 112 citations

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.

1993 • 91 citations

Iatrogenic Immunization with Bovine Thrombin: A Mechanism for Prolonged Thrombin Times after Surgery

1989 • 90 citations

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations

1993 • 85 citations

Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves [see comments]

1988 • 80 citations

Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients

1993 • 70 citations

Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child

1994 • 66 citations

Hemorrhagic death associated with a high titer factor V inhibitor

1978 • 61 citations

Factor V anticoagulants: clinical, biochemical, and immunological observations

1970 • 60 citations

Acquired Inhibitors of Factor V

1978 • 58 citations

Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin

1994 • 55 citations

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

1992 • 47 citations

Isolation and characterization of an acquired antithrombin antibody

1990 • 41 citations

Isolation and characterization of an acquired antithrombin antibody

1990 • 39 citations

A Circulating Inhibitor (Anti-AcG) Specific for the Labile Factor-V of the Blood-Clotting Mechanism

1958 • 36 citations

Partial Characterization of an Autoantibody Recognizing the Secondary Binding Site(s) of Thrombin in a Patient with Recurrent Spontaneous Arterial Thrombosis

1992 • 25 citations

DEVELOPMENT OF ANTI‐BOVINE THROMBIN ANTIBODIES FOLLOWING NEUROSURGICAL PROCEDURES

1990 • 20 citations

An autoantibody directed against human thrombin anion-binding exosite in a patient with arterial thrombosis: effects on platelets, endothelial cells, and protein C activation

1994 • 16 citations

Factor V inhibitor associated with immune complex formation.

1986 • 13 citations

[Acquired factor V inhibitor treated with intravenous immunoglobulins].

1992 • 10 citations

Cited By (0)

Loading...